Semaglutide is the active ingredient in Novo Nordisk's injectable drugs Ozempic and Wegovy, as well as the oral tablet Rybelsus [Source: nationalpost.com/news/canada/generic-versions-of-weight-loss-drugs-should-arrive-on-canadian-pharmacy-shelves-this-summer]
it began prescribing weight loss drugs in 2022
Topics not covered include the links between mast cells and multiple sclerosis, dementia, cancer, Crohns, ALS, endometriosis, Hidradenitis suppurativa, and osteoporosis
Your doctor should monitor your blood pressure and heart rate throughout treatment
Results will depend on factors like consistency, lifestyle habits, and your bodys response to treatment
\Safety Profile: Mild-to-moderate GI side effects, usually resolving with dose titration